Altss Research / Venture case 30
Proteus Digital Health
Proteus Digital Health obtained confirmation of a Chapter 11 liquidation plan in November 2020 after a court-approved sale of technology assets to Otsuka.
Altss Research · Evidence reviewed · Historical event record
Historical private valuation
$1.5bnThe original NBER research table lists Proteus Digital Health’s April 2016 private round at $1.5 billion post-money, separately from its modelled fair value.
Wind-down
No sale priceChapter 11 liquidation plan confirmed. Bankruptcy counsel reported confirmation of the debtor’s liquidation plan on November 16, 2020. The confirmation month is used because the announcement does not state the exact order-entry date.
These figures have different valuation bases and dates. Their difference is not a measure of investor losses. Methodology ↗
The documented timeline
Private financing benchmark
The original research table identifies the round month and post-money figure.
Asset-sale approval reported
Debtor’s counsel reported court approval of the proposed $15 million-plus sale to Otsuka America Pharmaceutical, including preservation of jobs.
Liquidation plan confirmed
Debtor’s counsel reported unanimous acceptance by voting creditors and confirmation without a hearing.
Source documents
Publication and access dates identify the evidence used for this case.
William Gornall and Ilya A. Strebulaev / NBER · Primary source · Published Oct 2017 · Accessed Oct 26, 2026
Goodwin (bankruptcy counsel) · Primary source · Published Aug 20, 2020 · Accessed Oct 26, 2026
Goodwin (bankruptcy counsel) · Primary source · Published Nov 16, 2020 · Accessed Oct 26, 2026
Logo: Proteus Digital Health logo source. Company trademark rights remain.